PT1038001E - Expressao constitutiva de particulas do tipo hiv nao infecciosas - Google Patents

Expressao constitutiva de particulas do tipo hiv nao infecciosas

Info

Publication number
PT1038001E
PT1038001E PT98960976T PT98960976T PT1038001E PT 1038001 E PT1038001 E PT 1038001E PT 98960976 T PT98960976 T PT 98960976T PT 98960976 T PT98960976 T PT 98960976T PT 1038001 E PT1038001 E PT 1038001E
Authority
PT
Portugal
Prior art keywords
particles
constitutive expression
hiv
modified
genome
Prior art date
Application number
PT98960976T
Other languages
English (en)
Portuguese (pt)
Inventor
Rovinski Benjamin
Yao Fei-Long
Cao Shi Xian
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25537545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1038001(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Publication of PT1038001E publication Critical patent/PT1038001E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT98960976T 1997-12-16 1998-12-14 Expressao constitutiva de particulas do tipo hiv nao infecciosas PT1038001E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/991,773 US6121021A (en) 1997-12-16 1997-12-16 Constitutive expression of non-infectious HIV-like particles

Publications (1)

Publication Number Publication Date
PT1038001E true PT1038001E (pt) 2006-07-31

Family

ID=25537545

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98960976T PT1038001E (pt) 1997-12-16 1998-12-14 Expressao constitutiva de particulas do tipo hiv nao infecciosas

Country Status (12)

Country Link
US (2) US6121021A (enExample)
EP (1) EP1038001B8 (enExample)
JP (1) JP2004509601A (enExample)
AT (1) ATE318909T1 (enExample)
AU (1) AU749174B2 (enExample)
BR (1) BR9813626A (enExample)
CA (1) CA2312943C (enExample)
DE (1) DE69833686T2 (enExample)
DK (1) DK1038001T3 (enExample)
ES (1) ES2262250T3 (enExample)
PT (1) PT1038001E (enExample)
WO (1) WO1999031250A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080408A (en) * 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
EP1083230A1 (en) * 1999-09-10 2001-03-14 Academisch Medisch Centrum Amsterdam Viral replicons and viruses dependent on inducing agents
US20040105871A1 (en) * 2000-03-02 2004-06-03 Robinson Harriet L. Compositions and methods for generating an immune response
AU2002211948B2 (en) 2000-03-02 2007-09-13 Emory University DNA expression vectors and methods of use
US8623379B2 (en) * 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
WO2002072754A2 (en) * 2001-03-08 2002-09-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mva expressing modified hiv envelope, gag, and pol genes
EP1776961A1 (en) * 2000-04-27 2007-04-25 Sanofi Pasteur Limited Immunizing against HIV infection
DK1280551T3 (da) * 2000-04-27 2007-05-21 Sanofi Pasteur Ltd Vacciner mod HIV-infektion
US7122180B2 (en) * 2000-10-23 2006-10-17 Children's Medical Center Corporation DNA vectors containing mutated HIV proviruses
US20060088909A1 (en) * 2002-05-17 2006-04-27 Compans Richard W Virus-like particles, methods of preparation, and immunogenic compositions
US9045727B2 (en) * 2002-05-17 2015-06-02 Emory University Virus-like particles, methods of preparation, and immunogenic compositions
CA2537953A1 (en) * 2003-09-09 2005-03-17 Virxsys Corporation Lentivirus vector-based approaches for generating an immune response to hiv in humans
US20090257983A1 (en) * 2008-04-11 2009-10-15 Scheiber Lane Bernard Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cells
US20110293694A1 (en) * 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance vector therapy method
US20110293693A1 (en) * 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance vector therapy
DK2694101T3 (en) 2011-04-06 2017-01-09 Biovaxim Ltd Pharmaceutical compositions for the prevention and / or treatment of HIV disease in humans

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
EP0496794A1 (en) * 1989-10-16 1992-08-05 Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor
CA2068713A1 (en) * 1989-11-20 1991-05-21 Omar K. Haffar Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
EP0527760B1 (en) * 1990-04-03 1995-07-19 Genentech, Inc. Methods and compositions for vaccination against hiv
JPH08500005A (ja) * 1992-03-27 1996-01-09 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ 非感染性ｈｉｖ粒子およびその用途
AU700371B2 (en) * 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
RU2201421C2 (ru) * 1993-06-09 2003-03-27 Коннот Лабораториз Лимитед Синтетический пептид hiv (варианты), иммуногенная композиция для индукции иммунного ответа против пептидов hiv, диагностический набор для определения hiv-специфичных антител
US6080408A (en) * 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
WO1998017815A1 (en) * 1996-10-17 1998-04-30 Oxford Biomedica (Uk) Limited Retroviral vectors
JP4312265B2 (ja) * 1997-04-09 2009-08-12 ラング−ジ チャン ワクチン評価のための動物モデル
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles

Also Published As

Publication number Publication date
ATE318909T1 (de) 2006-03-15
AU749174B2 (en) 2002-06-20
CA2312943C (en) 2009-02-24
AU1657799A (en) 1999-07-05
DK1038001T3 (da) 2006-07-10
ES2262250T3 (es) 2006-11-16
DE69833686D1 (de) 2006-04-27
CA2312943A1 (en) 1999-06-24
DE69833686T2 (de) 2006-11-30
BR9813626A (pt) 2002-07-23
US6121021A (en) 2000-09-19
JP2004509601A (ja) 2004-04-02
EP1038001A2 (en) 2000-09-27
EP1038001B1 (en) 2006-03-01
EP1038001B8 (en) 2006-09-13
US6572863B1 (en) 2003-06-03
WO1999031250A3 (en) 1999-08-19
WO1999031250A2 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
PT1038001E (pt) Expressao constitutiva de particulas do tipo hiv nao infecciosas
PL332876A1 (en) Lentoviral vectors
ATE253259T1 (de) Herstellung von tubulären brennstoffzellen, brennstoffzellenmodulen, grundelementen und ionentauschermembranen
DK0452484T3 (da) Fremstilling af proteiner ved homolog rekombination
TR199903234T2 (xx) Erkek doku tercih edilen d�zenleyici b�lge ve kullan�m�.
NO983102D0 (no) Uttrykk og forsterkning av sekvenselementer (EASE) for eukaryote ekspresjonssystemer
WO2002088346A3 (en) A system for inducible expression in eukaryotic cells
EP0320500A3 (en) Non-oncogenic ti plasmid vector system and recombinant dna molecules for the introduction of expressible genes into plant cell genomes
NO995475L (no) Kjemiske forbindelser
DK1170376T3 (da) Fremgangsmåde til fremstilling af L-aminosyre eller nukleinsyre ved anvendelse af mikroorganisme
TR199801933A2 (xx) Biyolojik olarak tolare edilebilen d���k molek�ler polietileniminler.
AU634289B2 (en) A multifunctional rna having self-processing activity, the preparation thereof and the use thereof
AU5539898A (en) Nucleic acid construct for the cell cycle regulated expression of structural genes
WO2002000871A3 (de) Verfahren zur einbringung von nukleinsäuren und anderen biologisch aktiven molekülen in der kern höherer eukaryontischer zellen mit hilfe elektrischen stroms
DK0843731T3 (da) Adenovirusvektorer til genterapi
DE3577994D1 (de) Vergroessernde virale dna-segmente.
DK1165797T3 (da) Partikler til genterapi
EP0336383A3 (en) Novel recombinant human lymphotoxin
SE9701454D0 (sv) new DNA sequences and a process for enzyme manufacture
HUP0102413A1 (hu) Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk
HUP9902585A2 (hu) Replikálódó molekulák in vivo előállítása
WO2001083822A3 (en) Use of representations of dna for genetic analysis
DK176387D0 (da) Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker
PT1032418E (pt) Replicoes compactos do virus epstein-barr
Acun Saray-Bosna Ve Travnik Saat Kuleleri